Mar 29, 2025

Featuring an interview with Dr Christopher L Moertel, including the following topics:

• Overview of neurofibromatosis type 1(NF1) (0:00)
• Cancer in NF1 (8:38)
• Dermatologic manifestations of NF1 (16:57)
• Treatment options for NF1 (20:43)
• Malignant peripheral nerve sheath tumors (MPNST) (25:14)
• FDA-approved MEK inhibitors...

Mar 28, 2025

Featuring a slide presentation and related discussion from Dr Christopher L Moertel, including the following topics:

• Overview of neurofibromatosis (0:00)
• Common clinical manifestations of neurofibromatosis type 1 (NF1) (14:13)
• Role of MEK inhibitors in the management of NF1 plexiform neurofibromas (29:30)

Mar 27, 2025

Featuring an interview with Dr Sara A Hurvitz, including the following topics:

• Role of endocrine therapy in the management of HER2-positive breast cancer; implications of the Phase III PATINA study (0:00)
• Case: A woman in her mid 60s with node-negative, HR-positive, HER2-negative localized breast cancer and a...

Mar 24, 2025

Featuring an interview with Dr Tiffany A Richards, including the following topics:

• Current treatment landscape for multiple myeloma (MM) (0:00)
• CAR (chimeric antigen receptor) T-cell therapy for the management of MM (10:22)
• Bispecific antibodies for relapsed/refractory MM (24:26)
• Case: A woman in her early 80s with...

Mar 21, 2025

Featuring an interview with Dr Komal Jhaveri, including the following topics:

• Emerging treatment options for advanced ER-positive breast cancer (0:00)
  • Burstein H. Emerging treatment options for advanced ER+ breast cancer. San Antonio Breast Cancer Symposium 2024;Abstract GS1-01 Discussant.
• Elacestrant real-world...